The identified truncating PALB2 c.1592delT mutation has been identified as a breast cancer susceptibility gene in the Finnish population with a prevalence of 0.2% and a 6-fold increased risk of breast cancer in the general population [19, 20, 34]. The gene discussed is PALB2; the disease is breast carcinoma.